Article
Inhaled Aviptadil for the treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo controlled multicentre trial.
2022-04-21
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Despite the fast establishment of new therapeutic agents in the management of COVID-19 and large-scale vaccination campaigns since the beginning of the SARS-CoV-2 pandemic in early 2020, severe disesase-courses still represent a threat, especially to patients with risk factors. This indicates the need for alternative strategies to prevent respiratory complicatio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 240d5b4f-d46e-523a-9abf-70f53b4a4f83
- DOI
- 10.21203/rs.3.rs-1507210/v1
